Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 4/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.47 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10295457 | 0.98 | ALDH1A1 (0.47) | ADORA1ADORA3ADORA2BADORA2AALDH1A1 | |
| SCHEMBL29559312 | 0.91 | ADORA1 (0.41) | ADORA1ADORA3ADORA2BADORA2AALDH1A1 | |
| SCHEMBL28716830 | 0.91 | ADORA1 (0.41) | ADORA1ADORA3ADORA2BADORA2AALDH1A1 | |
| SCHEMBL24162456 | 0.86 | ADORA3 (0.38) | ADORA1ADORA3ADORA2BADORA2AALDH1A1 | |
| SCHEMBL14560680 | 0.85 | ALDH1A1 (0.47) | ADORA1ADORA3ADORA2BADORA2AALDH1A1 | |
| SCHEMBL20855330 | 0.84 | TDP1 (0.54) | ADORA1ADORA3ADORA2BADORA2AALDH1A1 | |
| SCHEMBL14560685 | 0.83 | ALDH1A1 (0.38) | ADORA1ADORA3ADORA2BADORA2AALDH1A1 | |
| SCHEMBL14560724 | 0.82 | PTGS2 (0.44) | ADORA1ADORA3ADORA2BADORA2AALDH1A1 | |
| SCHEMBL13376977 | 0.82 | DHODH (0.55) | ADORA1ADORA3ADORA2BADORA2AALDH1A1 | |
| SCHEMBL10295465 | 0.81 | CTSS (0.46) | ADORA1ADORA3ADORA2BADORA2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114277389-B | Method for synthesizing quinoline derivative by utilizing pyridinium photoelectrocatalysis Minisci reaction | 齐鲁工业大学 | 2023-09-19 | — | — | CN | disclosed |
| CN-114277389-A | Method for synthesizing quinoline derivative by utilizing pyridinium photoelectrocatalysis Minisci reaction | 齐鲁工业大学 | 2022-04-05 | — | — | CN | disclosed |
| EP-1097980-B1 | Bathophenanthroline compound and process for preparing same | SONY CORP (JP) | 2012-07-04 | — | — | EP | disclosed |
| EP-1097981-B1 | Organic electroluminescent device | SONY CORP (JP) | 2010-04-14 | — | — | EP | disclosed |
| US-7186469-B2 | Bathophenanthroline compound and EL device | SONY CORPORATION (JP) | 2007-03-06 | — | — | US | disclosed |
| US-7186469-B2 | Bathophenanthroline compound and EL device | SONY CORPORATION (JP) | 2007-03-06 | — | — | US | disclosed |
| US-7186469-B2 | Bathophenanthroline compound and EL device | SONY CORPORATION (JP) | 2007-03-06 | — | — | US | disclosed |
| US-6972334-B1 | Bathophenathroline compound and process for preparing same | SONY CORPORATION (JP) | 2005-12-06 | — | — | US | disclosed |
| US-20050154208-A1 | Device utilizing bathophenanthroline compound and process for preparing same | SHIBANUMA TETSUO (JP) | 2005-07-14 | — | — | US | disclosed |
| EP-1097980-A2 | Bathophenanthroline compound and process for preparing same | SONY CORPORATION (JP) | 2001-05-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154208-A1 | Device utilizing bathophenanthroline compound and process for preparing same | BZW1, BZW2, AHR | ADORA1 1098/4885ADORA3 2788/4885ADORA2B 1725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.